C. Blais et al., Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction, PEPTIDES, 22(6), 2001, pp. 953-962
The purposes of this study were to evaluate and to compare the effects of s
imultaneous angiotensin-converting enzyme (ACE) and neutral endopeptidase 2
4.11 (NEP) inhibition by the vasopeptidase inhibitor omapatrilat (1 mg.kg(-
1).day(-1)) with those of the selective ACE inhibitor enalapril (1 mg.kg(-1
).day(1)) on survival, cardiac hemodynamics, and bradykinin (BK) and des-Ar
g(9)-BK levels in cardiac tissues 24 h after myocardial infarction (MI) in
rats. The effect of the co-administration of both B, and B, kinin receptor
antagonists (2.5 mg.kg(-1.) day(-1) each) with metallopeptidase inhibitors
was also evaluated. The pharmacological treatments were infused subcutaneou
sly using micro-osmotic pumps for 5 days starting 4 days before the ligatio
n of the left coronary artery. Immunoreactive kinins were quantified by hig
hly sensitive and specific competitive enzyme immunoassays. The post-MI mor
tality of untreated rats with a large MI was high; 74% of rats dying prior
to the hemodynamic study. Mortality in the other MI groups was not signific
antly different from that of the untreated MI rats. Cardiac BK levels were
not significantly different in the MI vehicle-treated group compared with t
he sham-operated rats. Both omapatrilat and enalapril treatments of MI rats
significantly increased cardiac BK concentrations compared with the sham-o
perated group (P < 0.05). However, cardiac BK levels were significantly inc
reased only in the MI omapatrilat-treated rats compared with the MI vehicle
-treated group (P < 0.01). Cardiac des-Arg(9)-BK concentrations were not si
gnificantly modified by MI, and MI with omapatrilat or enalapril treatment
compared with the sham-operated group. The co-administration of both kinin
receptor antagonists with MI omapatrilat- and enalapril-treated rats had no
significant effect on cardiac BK and des-Arg(9)-BK levels. Thus, the signi
ficant increase of cardiac BK concentrations by omapatrilat could be relate
d to a biochemical or a cardiac hemodynamic parameter on early (24 h) post-
MI state. (C) 2001 Elsevier Science Inc. All rights reserved.